News Releases
GLP-1 treatment linked to lower risk of hospitalization and death in older adults with fatty liver disease
A new Research Institute Houston Methodist study finds that older adults with metabolic dysfunction-associated steatotic liver disease (MASLD) who received GLP-1-based treatment experienced significantly lower risks of liver disease-related complications, hospitalization and death, compared with similar patients who did not receive the treatment.
Researchers found that patients receiving GLP-1 therapy had a 28% lower risk of hepatic decompensation, a serious complication of advanced liver disease, and a 45% lower risk of death from any cause. They also experienced fewer hospitalizations during follow-up.
Houston Methodist researchers receive NIH grant to investigate the brain’s role in common urinary disorder
Houston Methodist researchers have been awarded a five-year, $3.28 million grant from the National Institutes of Health to study how the brain controls bladder storage and emptying in people with underactive bladder, a condition that can make urination difficult or impossible and leave patients with few effective treatment options.
Dr. Rachel High, research director of the Center for Restorative Pelvic Medicine and professor of Obstetrics & Gynecology and Urology at Houston Methodist, is the study’s principal investigator, while Dr. Rose Khavari, professor of urology at Houston Methodist Research Institute will serve as the co-principal investigator.
Houston Methodist hospitals recognized as 2026 top performers by Vizient
All eight Houston Methodist acute care hospitals are top performers in Vizient's Bernard A. Birnbaum, MD, Quality Leadership annual rankings, which provide a national hospital scorecard focused on patient safety and quality metrics.
Houston Methodist Hospital finished No. 3 in its cohort for the second consecutive year — the hospital’s highest ranking. In addition, all seven Houston Methodist network hospitals ranked among the top 10 in their respective surveys, with two – Houston Methodist Willowbrook Hospital and Houston Methodist Baytown Hospital – ranked No. 1 in their respective cohorts.